Public filings / DNTH on Yahoo Finance (opens in a new tab)
DNTH: insider buying, 13F holders, analyst moves
Dianthus Therapeutics Inc - US
A summary of public filings about Dianthus Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold DNTH
Combined reported value $240.6M; 2 sold out since Q1 2026.
Holders among our 100 managers: 0 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deerfield Company | $109.7M | 1.14% | Added |
| Baker Bros. Advisors | $83.1M | 0.42% | Unchanged |
| RTW Investments | $24.2M | 0.21% | Unchanged |
| Samlyn Capital | $19.1M | 0.32% | Trimmed |
| Tudor Investment | $3.6M | 0.01% | New |
| Polen Capital | $910K | 0.01% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.